Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China · Delayed Price · Currency is CNY 79.29
-0.92 (-1.15%)
Nov 3, 2025, 2:45 PM CST
SHE:300573 Revenue
Shenyang Xingqi Pharmaceutical had revenue of 740.99M CNY in the quarter ending September 30, 2025, with 35.34% growth. This brings the company's revenue in the last twelve months to 2.41B, up 33.62% year-over-year. In the year 2024, Shenyang Xingqi Pharmaceutical had annual revenue of 1.94B with 32.42% growth.
Revenue (ttm)
2.41B
Revenue Growth
+33.62%
P/S Ratio
8.17
Revenue / Employee
992.51K
Employees
2,426
Market Cap
19.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.94B | 475.82M | 32.42% |
| Dec 31, 2023 | 1.47B | 217.71M | 17.42% |
| Jan 1, 2023 | 1.25B | 221.94M | 21.59% |
| Jan 1, 2022 | 1.03B | 339.23M | 49.26% |
| Dec 31, 2020 | 688.68M | 146.25M | 26.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |